Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies
NCT05807659
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Myeloid Malignancies
Interventions
DRUG:
fractionated busulfan-based conditioning regimen
Sponsor
Sichuan University